Medacta Group SA (SWX:MOVE)
113.40
-0.20 (-0.18%)
Oct 2, 2026, 5:30 PM CET
Medacta Group Revenue
Medacta Group had revenue of 368.17M EUR in the half year ending June 30, 2026, with 27.55% growth. This brings the company's revenue in the last twelve months to 707.85M, up 9.56% year-over-year. In the year 2025, Medacta Group had annual revenue of 683.83M with 15.79% growth.
Revenue (ttm)
707.85M EUR
Revenue Growth
+9.56%
P/S Ratio
3.46
Revenue / Employee
311.42K EUR
Employees
2,273
Market Cap
2.26B CHF
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 683.83M | 93.25M | 15.79% |
| Dec 31, 2024 | 590.58M | 79.80M | 15.62% |
| Dec 31, 2023 | 510.78M | 73.66M | 16.85% |
| Dec 31, 2022 | 437.12M | 74.00M | 20.38% |
| Dec 31, 2021 | 363.13M | 60.63M | 20.04% |
| Dec 31, 2020 | 302.49M | -8.13M | -2.62% |
| Dec 31, 2019 | 310.62M | 38.01M | 13.94% |
| Dec 31, 2018 | 272.61M | 27.93M | 11.41% |
| Dec 31, 2017 | 244.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 45.81B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.79B |
| Galenica AG | 4.29B |
| Siegfried Holding AG | 1.34B |
| Aevis Victoria | 1.05B |
| Tecan Group AG | 870.53M |
Medacta Group News
- 17 days ago - Medacta Group initiated with a Hold at Deutsche Bank - TheFly
- 21 days ago - Medacta Group price target lowered to CHF 180 from CHF 185 at Berenberg - TheFly
- 23 days ago - Medacta Group Earnings Call Transcript: H1 2026 - Transcripts
- 23 days ago - Medacta Group Quarterly report: H1 2026 - Filings
- 23 days ago - Medacta Group Slides: H1 2026 - Filings
- 23 days ago - Medacta Group Earnings release: H1 2026 - Filings
- 2 months ago - Medacta Group Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Medacta Group Earnings release: Q2 2026 - Filings